Natco Pharma to commence Galtiramer Acetate production for Mylan - Pharmaceutical Business review

17 Jan 2012

Natco Pharma to commence Galtiramer Acetate production for Mylan

India-based Natco Pharma is all set to initiate the production of multiple sclerosis drug, Galtiramer Acetate for Mylan at its manufacturing plant.

Natco Pharma chief financial officer P Bhaskara Narayana said that the facility which is worth INR 910m ($17.88m) is ready.

"The actual production in the dedicated multiproduction block will commence by the end of this quarter," Business Line quotes Narayana as saying.

Currently, validation batches are being manufactured at the facility, the news agency reported.

Drug Discovery